InVivoPlus anti-mouse CD16/CD32 [2.4G2]

Monitoring T cell-dendritic cell interactions in vivo by intercellular enzymatic labelling. Pasqual G et al., 2018 Jan 25, Nature

In vivo imaging reveals a tumor-associated macrophage-mediated resistance pathway in anti-PD-1 therapy.

CD47 blockade triggers T cell-mediated destruction of immunogenic tumors. Liu X et al., 2015 Oct, Nat Med

IL-7/IL-7 Receptor Signaling Differentially Affects Effector CD4+ T Cell Subsets Involved in Experimental Autoimmune Encephalomyelitis. Arbelaez CA et al., 2015 Sep 1, J Immunol

Effector lymphocyte-induced lymph node-like vasculature enables naive T-cell entry into tumours and enhanced anti-tumour immunity. Peske JD et al., 2015 May 13, Nat Commun

A monoclonal antibody with anti-D-like activity in murine immune thrombocytopenia requires Fc domain function for immune thrombocytopenia ameliorative effects. Yu X et al., 2015 Jun, Transfusion

Loss of signalling via Galpha13 in germinal centre B-cell-derived lymphoma. Muppidi JR et al., 2014 Dec 11, Nature

The function of the chemokine receptor CXCR6 in the T cell response of mice against Listeria monocytogenes. Heesch K et al., 2014, PLoS One

FoxP3+ regulatory T cells promote influenza-specific Tfh responses by controlling IL-2 availability. Leon B et al., 2014 Mar 17, Nat Commun

Irradiation and anti-PD-L1 treatment synergistically promote antitumor immunity in mice. Deng L et al., 2014 Feb, J Clin Invest